Stay updated on BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page.

Latest updates to the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page
- Check5 days agoChange DetectedDifference0.1%

- Check12 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' topic from the study's metadata. This changes the disease-related keywords associated with the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe recruitment site was updated to add Aarhus N (8200) and remove Aarhus C (8000); related topics 'Multiple myeloma' and 'MedlinePlus Genetics' were added.SummaryDifference0.2%

- Check33 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice and operating status message (Revision: v3.4.1); these changes are peripheral to the trial details and do not affect study data or eligibility, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange DetectedNotice: government funding lapse banner added to the page, and the site revision updated to v3.4.1. Removed 'Multiple myeloma' and related topics 'MedlinePlus Genetics' (and prior revision note 'v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded: Show glossary toggle, Last Update Submitted that Met QC Criteria, No FEAR Act Data notice, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page.